Health Care/Hospital
Henlius Deepens Collaboration with Intas to bring Henlius' Novel anti-PD-1 mAb Serplulimab to Europe and India
* The footprint of serplulimab now includes the United States, Europe, Southeast Asia, MENA, and India * Intas to develop and commercialise serplulimab in Europe and India; Henlius to receive €42 million upfront payment, double-digit royalties and up to €143 million in regulatory and commerci...
2023-10-27 19:13
6016
Singapore PM Office awards Public Service Medal to Muhammed Aziz Khan
SINGAPORE, Oct. 27, 2023 /PRNewswire/ -- Chairman of Summit Group, Muhammed Aziz Khan, received the Public Service Medal (COVID-19) at the National Awards for his outstanding contribution to society during the pandemic. On behalf of the Prime Minister's Office ofSingapore, Minister for Health, Mr...
2023-10-27 17:36
1846
World Stroke Day: World Stroke Organization calls for Action on Prevention as Global Stroke Mortality is Predicted to Rise by 50%
GENEVA, Oct. 27, 2023 /PRNewswire/ -- The World Stroke Organization (WSO
2023-10-27 15:00
2668
NX Ireland Acquires GDP Certification for Company-owned Warehouse
TOKYO, Oct. 27, 2023 /PRNewswire/ -- Nippon Express (Ireland) Ltd. (hereafter "NX Ireland"), a group company of NIPPON EXPRESS HOLDINGS, INC., has received Good Distribution Practice (GDP) certification from the Irish Exporters Association (IEA), effectiveSeptember 21, for the temporary storage a...
2023-10-27 14:00
2100
Everest Medicines Announces New Drug Application Approval by the Pharmaceutical Administration Bureau of Macau for Nefecon® for the Treatment of Primary IgA Nephropathy
SHANGHAI, Oct. 27, 2023 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest," or the "Company"), a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative medicines and vaccines, announced today that the Pharmaceutical Administration Bureau of...
2023-10-27 13:45
2160
Everest Medicines Announces Poster Presentation at ASN Kidney Week on Nefecon® Chinese Patient Data and to Hold Conference Calls
SHANGHAI, Oct. 27, 2023 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative medicines and vaccines, today announced that it will make a late-breaking poster present...
2023-10-27 08:22
2227
Noted National TCM Master Inaugurates New Infinitus Research and Technology Laboratory
GUANGZHOU, China, Oct. 27, 2023 /PRNewswire/ – The unveiling ceremony for the joint laboratory, a collaboration between Infinitus and theShandong University of Traditional Chinese Medicine dedicated toXuezhuo-turbid blood research, took place at Infinitus Plaza. The event drew attention from over...
2023-10-27 08:00
1956
A large international study of migraine reveals new biological pathways for treatment
REYKJAVIK, Iceland, Oct. 26, 2023 /PRNewswire/ -- A large international study led by deCODE Genetics on the genetics of migraine provides novel insights into the biology of migraine enabling detection of rare variants protecting against migraine, opening an avenue for potential development of nov...
2023-10-26 23:00
2105
GLOBAL SURVEY IDENTIFIES COST OF LIVING, LONELINESS, TECHNOLOGY, CLIMATE CONCERNS DEEPENING
Global poll sampling 50,000 people from 23 countries highlights increasing discontent across a range of issues RIYADH, Saudi Arabia, Oct. 26, 2023 /PRNewswire/ -- A global survey commissioned by non-profit Future Investment Initiative (FII) Institute, in partnership with Accenture is released to...
2023-10-26 22:28
2754
ZEISS continues to expand its clinical workflows and digital portfolio, presenting new tools and solutions at AAO 2023
* ZEISS CT LUCIA 621P is now available for calculation on the ZEISS AI IOL Calculator. * New ZEISS PROSPARA digital marketing software within the ZEISS Corneal Refractive Workflow helps enhance online visibility for refractive practices. * ZEISS VISULAS yag therapeutic laser receives 510k cl...
2023-10-26 21:00
1612
YS Biopharma Announces Receipt of Nasdaq Notice
GAITHERSBURG, Md., Oct. 26, 2023 /PRNewswire/ -- YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious disea...
2023-10-26 20:30
3448
Fapon, LASCCO, Abionic Formed Strategic Collaboration for PSP Sepsis Diagnosis in China
LAUSANNE, Switzerland, Oct. 26, 2023 /PRNewswire/ -- Fapon, a leading life sciences company, entered into a strategic cooperation agreement with two Swiss biotech companies LASCCO SA and Abionic SA, that granted Fapon an exclusive license to utilize the pancreatic stone protein (PSP) biomarker fo...
2023-10-26 18:33
2371
Biosyngen's BST02, the World's First TIL Therapy for Liver Cancer, is Granted an IND Approval by FDA
SINGAPORE, Oct. 26, 2023 /PRNewswire/ -- On October 26, 2023, Biosyngen's TIL therapy BST02 for liver cancer was granted an approval for clinical trial by the US FDA. BST02, a breakthrough product in the field of cell and gene therapy, represents the world's first TIL therapy designed for the tre...
2023-10-26 18:18
2607
World Psoriasis Day 2023: Access for All
STOCKHOLM, Oct. 26, 2023 /PRNewswire/ -- Every year on World Psoriasis Day, October 29th, the international psoriatic disease community unites to raise awareness and fight for progress. The theme of 2023, "Access for All," underscores the vital need for Universal Health Coverage (UHC) to ensure t...
2023-10-26 16:00
2012
'MAKE WAVES FOR HONG KONG' By Splash Foundation To be held on November 4th, 2023
Olympic Swimmers and Business Leaders to Race Around Hong Kong To Address City's Chronic Swim Illiteracy * 5 teams, comprising 30 elite swimmers and business leaders, to undertake challenging 45-kilometre relay swim aroundHong Kong Island * The swim is expected to take 11-13 hours starting in...
2023-10-26 14:00
1939
Prof. Yongmei Yin at 2023 ESMO: SKB264 (MK-2870), an innovativeTROP2-ADC originating from Chinese biotech, achieves remarkable success in overcoming the therapeutic impasse in HR+/HER2- metastatic breast cancer
CHENGDU, China, Oct. 26, 2023 /PRNewswire/ -- The European Society for Medical Oncology (ESMO) convened its annual meeting inMadrid, Spain, from October 20th to 24th, 2023. As the preeminent academic gathering in the field ofoncology, it brought together global experts in oncology to share the la...
2023-10-26 12:58
2078
The International Diabetic Lower Extremity Symposium of the International Society of Regenerative Medicine and Wound Repair Held
PHUKET, Thailand, Oct. 26, 2023 /PRNewswire/ -- During the period from October 25 to 27, 2023, the International Diabetic Lower Extremity Symposium of the International Society of Regenerative Medicine and Wound Repair is held in Thailand. Over 200 experts and scholars from more than 20 countries ...
2023-10-26 10:29
1798
Qilu Pharmaceutical announces the latest results from its clinical study on QL1706, in combination with chemotherapy, as a first-line treatment for recurrent or metastatic cervical cancer
JINAN, China, Oct. 25, 2023 /PRNewswire/ -- On October 22, Qilu Pharmaceutical unveiled the latest findings from a multicenter, single-arm Phase II clinical trial at the European Society for Medical Oncology (ESMO) Annual Congress 2023. This trial studied the use of QL1706 (iparomlimab and tuvonr...
2023-10-25 22:33
2063
FDA Meeting Feedback Puts Turn Biotechnologies on Track to be First Longevity Company Taking Cell Rejuvenation Therapy to Clinic
* FDA INTERACT meeting reviews Turn Bio's ERA™ and eTurna™ technologies, approach and plans, paving way toward its IND * Company continues to pace industry's cell regeneration therapy progress MOUNTAIN VIEW, Calif., Oct. 25, 2023 /PRNewswire/ -- Turn Biotechnologies, a cell rejuvenation compa...
2023-10-25 20:30
1769
NEWLY-LAUNCHED AMAZFIT ACTIVE AND AMAZFIT ACTIVE EDGE INTRODUCE A STYLISH WAY TO STAY ACTIVE & STAY HEALTHY
Tailored for the modern-day city consumer, the Amazfit Active and Amazfit
Active Edge seamlessly blend style, functionality, and health, redefining what
it means to live an active lifestyle.
MILPITAS, Calif., Oct. 25, 2023 /PRNewswire/ -- Amazfit
2023-10-25 20:00
2128
Week's Top Stories
Most Reposted
Going Global: DCITS Embarks on International Expansion at Singapore Fintech Festival
[Picked up by 313 media titles]
2024-11-12 09:00
DKSH Healthcare and Euris Unveil CRM & MCE Platform "ConnectPlus" to Revolutionize APAC Healthcare Distribution
[Picked up by 294 media titles]
2024-11-13 09:00
Sobot Introduces its All-in-One Solution at GITEX Global 2024
[Picked up by 291 media titles]
2024-11-12 11:00
Ubiqconn Technology to Showcase Latest Marine Solutions at the 2024 International WorkBoat Show in New Orleans
[Picked up by 289 media titles]
2024-11-11 21:00
Oxygen, HubSpot's leading solutions partner in Hong Kong & Greater China Expands to UAE
[Picked up by 286 media titles]
2024-11-15 15:25
Most Read
DKSH Healthcare and Euris Unveil CRM & MCE Platform "ConnectPlus" to Revolutionize APAC Healthcare Distribution
2024-11-13 09:00
6744
Sobot Introduces its All-in-One Solution at GITEX Global 2024
2024-11-12 11:00
5924
Going Global: DCITS Embarks on International Expansion at Singapore Fintech Festival
2024-11-12 09:00
5699